Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis-Reference-Cited by-同舟云学术

Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis

Published:2020-10-23 Issue:12 Volume:55 Page:3384-3390
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol

Author:

Saad Anasemon¹,Young McKenzie R.²,Studtmann Anna E.³,Autry Elizabeth B.⁴⁵,Schadler Aric⁴⁶,Beckman Elizabeth J.⁴⁵^ORCID,Gardner Brian M.⁴⁵,Wurth Mark A.⁶,Kuhn Robert J.⁴⁵

Affiliation:

1. Department of Pharmacy NYU Langone Medical Center New York City New York USA

2. Department of Pharmacy Rush University Medical Center Chicago Illinois USA

3. Department of Pharmacy Practice and Science Norton Children's Hospital Louisville Kentucky USA

4. University of Kentucky College of Pharmacy Lexington Kentucky USA

5. Department of Pharmacy, Kentucky Children's Hospital University of Kentucky HealthCare Lexington Kentucky USA

6. Department of Pediatrics University of Kentucky College of Medicine Lexington Kentucky USA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.25066

Reference26 articles.

1. New and emerging targeted therapies for cystic fibrosis

2. Cystic Fibrosis Foundation Patient Registry 2017.Annual Data Report Bethesda MD 2018.

3. Aminoglycoside use in cystic fibrosis: therapeutic strategies and toxicity

4. Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations

5. Aminoglycosides: An Overview

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Necessity of Tobramycin trough Levels in Once Daily Iv-Treatment in Patients with Cystic Fibrosis;Klinische Pädiatrie;2024-01-29

2. Prevalence, trends and outcomes of long-term inhaled antibiotic treatment in people with cystic fibrosis without chronic Pseudomonas aeruginosa infection – A European cystic fibrosis patient registry data analysis;Journal of Cystic Fibrosis;2023-01

3. Aminoglycosides use has a risk of acute kidney injury in patients without prior chronic kidney disease;Scientific Reports;2022-10-14

4. Acute kidney injury in cystic fibrosis patients treated with intravenous colistimethate sodium or tobramycin;Journal of Antimicrobial Chemotherapy;2022-06-09

5. Assessment of Causality in Hospitalized Children With Aminoglycoside-Related Nephrotoxicity;Indian Pediatrics;2022-01-05